Description:

Supply of various medicinal products including Enfortumab vedotin, Sorafenibum 200 mg and 400 mg, Axicabtagene ciloleucel, and Brexucabtagene autoleucel as detailed in Attachment 2.

Awarded to:

Sorafenibum 200 mg

ASCLEPIOS SA, Wrocław (PL)

Sorafenibum 400 mg

ASCLEPIOS SA, Wrocław (PL)

Enfortumab vedotin

ASTELLAS PHARMA Sp. z o.o., Warszawa (PL)

Axicabtagene ciloleucel, Brexucabtagene autoleucel

GILEAD SCIENCES POLAND Sp. z o.o., Warszawa (PL)

Download full details as .pdf

The Buyer:

Narodowy Instytut Onkologii im. Marii Skłodowskiej–Curie - Państwowy Instytut Badawczy

CPV Code(s):

33690000 - Various medicinal products